ProShares Ultra Nasdaq Biotechnology (BIB)

NASDAQ: BIB · IEX Real-Time Price · USD
54.47
-0.95 (-1.71%)
At close: May 10, 2024, 4:00 PM
55.33
+0.86 (1.58%)
After-hours: May 10, 2024, 6:11 PM EDT
-1.71%
Assets $89.90M
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 1.63M
Dividend (ttm) $0.08
Dividend Yield 0.14%
Ex-Dividend Date Mar 20, 2024
Payout Ratio n/a
1-Year Return -4.52%
Volume 15,294
Open 55.24
Previous Close 55.42
Day's Range 54.32 - 55.72
52-Week Low 40.10
52-Week High 62.45
Beta 1.58
Holdings 228
Inception Date Apr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity
Category Trading--Leveraged Equity
Stock Exchange NASDAQ
Ticker Symbol BIB
ETF Provider ProShares
Index Tracked NASDAQ / Biotechnology

Top 10 Holdings

150.76% of assets
Name Symbol Weight
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG n/a 45.36%
NASDAQ BIO INDEX SWAP BNP n/a 36.94%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA n/a 19.37%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE n/a 13.06%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL n/a 6.57%
Amgen Inc. AMGN 6.55%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA n/a 5.98%
Regeneron Pharmaceuticals, Inc. REGN 5.83%
Vertex Pharmaceuticals Incorporated VRTX 5.81%
Gilead Sciences, Inc. GILD 5.29%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Mar 20, 2024 $0.04032 Mar 27, 2024
Dec 20, 2023 $0.03839 Dec 28, 2023
Dec 22, 2022 $0.01985 Dec 30, 2022
Sep 21, 2010 $0.011 Sep 28, 2010
Full Dividend History

News

There is no news available yet.